A detailed history of Org Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Org Partners LLC holds 356 shares of NVO stock, worth $31,580. This represents 0.01% of its overall portfolio holdings.

Number of Shares
356
Previous 2,329 84.71%
Holding current value
$31,580
Previous $332,000 87.35%
% of portfolio
0.01%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$119.07 - $145.42 $234,925 - $286,913
-1,973 Reduced 84.71%
356 $42,000
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $44,543 - $53,328
363 Added 18.46%
2,329 $332,000
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $200,748 - $267,218
1,966 New
1,966 $252,000
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $363 - $798
4 Added 8.51%
51 $51,000
Q2 2023

Jul 25, 2023

BUY
$155.98 - $172.65 $7,331 - $8,114
47 New
47 $8 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.